Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA-Reference-Cited by-同舟云学术

Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA

Published:2021-10-21 Issue: Volume: Page:
ISSN:1175-3277
Container-title:American Journal of Cardiovascular Drugs
language:en
Short-container-title:Am J Cardiovasc Drugs

Author:

Dhamane Amol D,Hernandez Inmaculada,Di Fusco Manuela,Gutierrez Cynthia,Ferri Mauricio,Russ Cristina,Tsai Wan-Lun,Emir Birol,Yuce Huseyin,Keshishian Allison

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40256-021-00501-w.pdf

Reference29 articles.

1. Shea JB, Sears SF. Cardiology patient pages. A patient’s guide to living with atrial fibrillation. Circulation. 2008;117(20):340–3. https://doi.org/10.1161/CIRCULATIONAHA.108.780577.

2. Marinigh R, Lip GY, Fiotti N, Giansante C, Lane DA. Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis. J Am Coll Cardiol. 2010;56(11):827–37. https://doi.org/10.1016/j.jacc.2010.05.028.

3. Sankaranarayanan R, Kirkwood G, Visweswariah R, et al. How does chronic atrial fibrillation influence mortality in the modern treatment era? Curr Cardiol Rev. 2015;11(3):190–8. https://doi.org/10.2174/1573403x10666140902143020.

4. Pastori D, Menichelli D, Del Sole F, Pignatelli P, Violi F. Long-term risk of major adverse cardiac events in atrial fibrillation patients on direct oral anticoagulants. Mayo Clin Proc. 2021;96(3):658–65. https://doi.org/10.1016/j.mayocp.2020.06.057.

5. Vranckx P, Valgimigli M, Heidbuchel H. The significance of drug-drug and drug-food interactions of oral anticoagulation. Arrhythm Electrophysiol Rev. 2018;7(1):55–61. https://doi.org/10.15420/aer.2017.50.1.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Medical Switching or Discontinuation Patterns among Patients with Non-Valvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States: A Claims-Based Analysis;Journal of Market Access & Health Policy;2024-09-02

2. Evaluating the effect of inequalities in oral anti-coagulant prescribing on outcomes in people with atrial fibrillation;European Heart Journal Open;2024-03-01

3. Non‑persistence to Oral Anticoagulation Therapy in Elderly Patients with Non‑valvular Atrial Fibrillation;Patient Preference and Adherence;2023-12

4. Unresolved issues in the use of direct acting oral anticoagulants;Expert Review of Cardiovascular Therapy;2023-10-20

5. Evaluating the Effect of Inequalities in Oral Anti-coagulant Prescribing on Outcomes in People with Atrial Fibrillation;2023-08-31